97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

14 trials found

diseases per page:

Showing 1 to 10 of 14 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-004878-26-PL (EUCTR)	18/01/2022	12/10/2021	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165in Participants with Moderate t ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Moderate to Severe Ulcerative Colitis. MedDRA version: 20.0;Level: PT;Classification code 10009900;T ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: TYK2 Inhibitor Other descriptive ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Canada;Poland;Australia;Netherlands;Germany;United Kingdom
2	EUCTR2020-004461-40-IT (EUCTR)	15/09/2021	18/10/2021	Long-term Safety and Efficacy of BMS-986165in Participants with Crohn's Disease or Ulcerative Coliti ...	An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of BMS-986 ...	moderate to severe Crohn's Disease (CD), moderate to severe Ulcerative Colitis (UC) MedDRA version: ...	Product Name: deucravacitinib Product Code: [BMS-986165] INN or Proposed INN: deucravacitinib	BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 2	United States;Portugal;Taiwan;Spain;Ireland;Russian Federation;Israel;Italy;Switzerland;France;Austr ...
3	EUCTR2020-004461-40-DE (EUCTR)	04/08/2021	12/05/2021	Long-term Safety and Efficacy of BMS-986165in Participants with Crohn’s Disease or Ulcerative Coliti ...	An Open-label, Multi-center Extension Study to Evaluate the Long-term Safety and Efficacy of BMS-986 ...	moderate to severe Crohn’s Disease (CD), moderate to severe Ulcerative Colitis (UC) MedDRA version: ...	Product Name: deucravacitinib Product Code: BMS-986165 INN or Proposed INN: deucravacitinib Other descr ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 2	United States;Portugal;Taiwan;Spain;Ireland;Russian Federation;Israel;Italy;Switzerland;France;Austr ...
4	NCT04613518 (ClinicalTrials.gov)	March 15, 2021	28/10/2020	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165in Participants With Moderate t ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Colitis, Ulcerative	Drug: BMS-986165;Other: Placebo Comparator	Bristol-Myers Squibb	NULL	Active, not recruiting	18 Years	65 Years	All	50	Phase 2	United States;Australia;Canada;Germany;Netherlands;Poland;Puerto Rico;United Kingdom
5	EUCTR2019-004878-26-NL (EUCTR)	10/02/2021	20/10/2020	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165in Participants with Moderate t ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Moderate to Severe Ulcerative Colitis. MedDRA version: 20.0;Level: PT;Classification code 10009900;T ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: TYK2 Inhibitor Other descriptive ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Canada;Australia;Germany;Netherlands;United Kingdom
6	EUCTR2019-004878-26-DE (EUCTR)	05/01/2021	24/08/2020	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165in Participants with Moderate t ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker ...	Moderate to Severe Ulcerative Colitis. MedDRA version: 20.0;Level: PT;Classification code 10009900;T ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: TYK2 Inhibitor Other descriptive ...	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Canada;Australia;Netherlands;Germany;United Kingdom
7	EUCTR2018-004694-27-FR (EUCTR)	06/07/2020	10/04/2020	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Poland;Australia;Germany;Japan;Korea, Republic of;United States;Russian Federation;Italy;United King ...
8	EUCTR2018-004694-27-DE (EUCTR)	24/09/2019	24/05/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	United States;Czechia;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Belgium; ...
9	EUCTR2018-004694-27-IT (EUCTR)	21/08/2019	25/01/2021	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: [BMS-986165]	BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 2	United States;Czechia;Russian Federation;Italy;United Kingdom;France;Hungary;Czech Republic;Belgium; ...
10	EUCTR2018-004694-27-CZ (EUCTR)	13/08/2019	19/07/2019	Safety and Efficacy of BMS-986165 Compared with Placebo in Subjects with Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-98616 ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165 Other descriptive nam ...	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	United States;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;A ...

First Previous1 2Next Last